Wednesday, 17 July 2019

Sinopharm to build China's largest R&D center

07 August 2013 | News | By BioSpectrum Bureau

Sinopharm Group will construct China's largest Biotechnology Research Institute in Wuhan East Lake High-tech Zone in a period of three years

Sinopharm Group will construct China's largest Biotechnology Research Institute in Wuhan East Lake High-tech Zone in a period of three years

Singapore: Sinopharm Group is going to build China's largest Biotechnology Research Institute in Wuhan East Lake High-tech Zone. The facility will showcase all of Sinopharm's existing biotech R&D resources under one roof.

The facility will be part of a Sinopharm subsidiary, the China Institute of Pharmaceutical Industry. Sinopharm highlighted that the institute will comprise of two-to-three separate buildings and will be constructed in a period of three years.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account



Podcast

 

Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls